Marcelle Pick raises concerns about prescribing Ozempic and Mounjaro to non-diabetics when long-term effects aren't well studied. She's observed patients develop gastroparesis and paralytic ileus, and questions whether these drugs' effects on neurotransmitters could create addiction-like behaviors.
Now, let me tell you some of my concerns. My concerns are that what I've seen clinically is that we're using a medication that we've not studied long term for people that are not diabetic. And what I'm seeing clinically is that so many people that have digestive issues before they start this treatment have then long term issues such as gastroparesis, paralytic ileus, which means the intestines become somewhat paralyzed. And in addition to that, they also have a lot of nausea and some vomiting. But my curiosity is really more about are there neurotransmitters that we really need to focus on that can actually help with the whole notion of addiction? So the saga continues.
